About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over thirteen years of extensive R&D, BLGO holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries.
With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BLGO has proven itself with over 90 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets.
“We take on some of the hardest challenges because we know our products and solutions are the real deal” – Dennis Calvert, CEO, and Chairman of the Board.
In 2007, serial entrepreneur, salesman, operator, and investor Dennis Calvert bonded with researcher and inventor Ken Code. Ken was a master observer in his prime and discovered that the iodine cycle held powerful properties that could be replicated in product design. Driven by a passion for protecting his father, Ken invented a novel way to combat nosocomial infections, which improved his father’s quality of life. Hence BioLargo’s slogan “make life better” was born.
BioLargo was founded with the goal of creating technology solutions that mimic natural processes that occur in water, air, and soil in order to solve some of the toughest environmental problems in the world. Since its inception, the company has exerted a continual effort to build and refine a portfolio of cleantech solutions, resulting in 20+ patents in air, water, and infection discoveries. The company is now home to a world-class team of environmental engineers, research scientists, sales professionals, and operators to expand into all things CleanTech and Sustainability, including water treatment, air quality control, and environmental remediation.
Winner of 2 “Innovator of the Year” awards, Technology Star, Top 50 Water Technology honors, Cleantech Company of the Year in Southern California and more.
BioLargo stands for high impact performance, innovation, and environmental technology, which has resulted in 80 grants to date. BLGO has invented, developed, and validated all of its cutting-edge solutions in-house because of its willingness to invest in R&D and do the hard work. We put the right infrastructure in place, established the right team, landed the right pilot projects, and have been on a journey of collaborations since inception. Our collaborations include major academic institutions around the world, like the University of Alberta, University of Tennessee, government funding agencies like the EPA-SBIR, National Science and Engineering Research Council of Canada (NSERC), National Research Council Canada (NRC-IRAP) with industry support from the likes of the Metropolitan Water District.
Parent/Subsidiary Distribution Model
BioLargo, Inc. provides financing and a hands-on approach to executing sales, marketing, commercialization, and distribution of the products through the subsidiaries. The subs are essentially commercial units, divisions, or product teams to take the products to market. This corporate structure provides more monetization options and allows more freedom for the respective CEOs to make decisions while at the same time allowing each business unit to ‘tap into’ the talent and resources of the other units to serve customers. The company is divided into its “Environmental Group” of subsidiaries, meaning BioLargo Water, BioLargo Engineering, and ONM Environmental, and its medical subsidiary Clyra Medical which is a minority interest asset run separately from the other business units.